EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open‐ended survey responses

Kerri Brown, Marisel Ponton, Elenita Davidson, Banu Arun iD, Robert J Volk iD, Sanjay Shete iD, Susan K Peterson, Sukh Makhnoon iD

Cancer · 2024

DOI: 10.1002/cncr.35429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Kerri Brown und 7 weiteren Autor:innen. Beteiligte Einrichtung: Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Genetic Counseling, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Cancer Center Support Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate variant classification and relaying reclassified results to patients is critical for hereditary cancer care delivery. Over a 5‐ to 10‐year period, 6%–15% of variants undergo reclassification. As the frequency of reclassifications increases, the issue of whether, how, when, and which providers should recontact patients becomes important but remains contentious.

Methods

The authors used inductive thematic analysis to analyze open‐ended comments offered by oncologists and genetic counselors (GCs) from a large national survey.

Results

Of the 634 oncologists and cancer GCs, 126 (20%) offered substantive free‐text comments. Four thematic areas emerged: 1) ambiguity over professional responsibility to recontact, 2) logistical challenges with recontact, 3) importance of inter‐institutional communication, and 4) suggested solutions. Some oncologists felt that laboratories, not them, are responsible for recontact; others believed that ordering providers/GCs were responsible; GCs readily acknowledged their own responsibility in recontact but added important caveats. Besides the lack of up‐to‐date patient contact information, providers raised unique challenges with recontact: financial instability of laboratories, lack of clinical resources, contacting family members, and accumulating burden of reclassifications. There were numerous calls for developing practice guidelines on prioritizing variants for recontact and discussion on whether duty for recontact may be fulfilled via unidirectional, low touch modalities. Potential solutions to recontact including national databases and patient facing databases were discussed.

Conclusions

The authors confirm previous themes of stakeholder opinions and add previously unreported contextual details to qualify those themes. Clarifying provider responsibilities through professional guidelines for reclassification and recontact addressing the subthemes identified here will better serve all constituencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic CounselingNeoplasmsHumansSurveys and QuestionnairesGenetic TestingOncologistsFemaleMaleGenetic Predisposition to DiseaseDuty to Recontact

Stichwörter der Autor:innen

cancergenetic counseloroncologistopen‐ended itemsqualitativereclassificationsurvey

Autor:innen und Institutionen

  • Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Clinical Cancer Genetics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Banu Arun, Robert J Volk, Sanjay Shete, Sukh Makhnoon

Förderung

  • NCI NIH HHS
  • Cancer Center Support Grant

Zitieren

APA

Brown, K., Ponton, M., Davidson, E., Arun, B., Volk, R. J., Shete, S., Peterson, S. K., & Makhnoon, S. (2024). What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open‐ended survey responses. Cancer. https://doi.org/10.1002/cncr.35429

Vancouver

Brown K, Ponton M, Davidson E, Arun B, Volk RJ, Shete S, et al. What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open‐ended survey responses. Cancer. 2024. doi:10.1002/cncr.35429

BibTeX
@article{Brown2024,
  author = {Brown, Kerri and Ponton, Marisel and Davidson, Elenita and Arun, Banu and Volk, Robert J and Shete, Sanjay and Peterson, Susan K and Makhnoon, Sukh},
  title = {What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open‐ended survey responses},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35429}
}
Kostenlos starten →